GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » Medifast Inc (NYSE:MED) » Definitions » PB Ratio

Medifast (Medifast) PB Ratio

: 1.72 (As of Today)
View and export this data going back to 1981. Start your Free Trial

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-18), Medifast's share price is $31.88. Medifast's Book Value per Share for the quarter that ended in Dec. 2023 was $18.49. Hence, Medifast's PB Ratio of today is 1.72.

Good Sign:

Medifast Inc stock PB Ratio (=1.72) is close to 10-year low of 1.7

The historical rank and industry rank for Medifast's PB Ratio or its related term are showing as below:

MED' s PB Ratio Range Over the Past 10 Years
Min: 1.7   Med: 6.46   Max: 28.93
Current: 1.72

During the past 13 years, Medifast's highest PB Ratio was 28.93. The lowest was 1.70. And the median was 6.46.

MED's PB Ratio is ranked better than
53.12% of 96 companies
in the Personal Services industry
Industry Median: 1.825 vs MED: 1.72

During the past 12 months, Medifast's average Book Value Per Share Growth Rate was 29.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 11.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 15.90% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 10.60% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Medifast was 149.30% per year. The lowest was -39.60% per year. And the median was 12.10% per year.

Back to Basics: PB Ratio


Medifast PB Ratio Historical Data

The historical data trend for Medifast's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medifast Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.30 14.70 11.99 8.09 3.64

Medifast Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.09 6.60 5.41 4.22 3.64

Competitive Comparison

For the Personal Services subindustry, Medifast's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medifast PB Ratio Distribution

For the Personal Services industry and Consumer Cyclical sector, Medifast's PB Ratio distribution charts can be found below:

* The bar in red indicates where Medifast's PB Ratio falls into.



Medifast PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Medifast's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=31.88/18.491
=1.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Medifast  (NYSE:MED) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Medifast PB Ratio Related Terms

Thank you for viewing the detailed overview of Medifast's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medifast (Medifast) Business Description

Traded in Other Exchanges
Address
100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
Executives
Jeffrey J Brown director 19900 MACARTHUR BLVD, SUITE 570, IRVINE CA 92612
Andrea B Thomas director C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Michael A. Hoer director MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202
Scott Schlackman director 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Hallquist Constance J. director 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Elizabeth A. Geary director C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Daniel R Chard director, officer: Chief Executive Officer NU SKIN ENTERPRISES, INC., 75 WEST CENTER STREET, PROVO UT 84601
Jonathan Barrett Mackenzie officer: VP, Finance & CAO 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Kevin G Byrnes director C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Michael C Macdonald director C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
James P. Maloney officer: Chief Financial Officer 415 HOLIDAY DRIVE, PITTSBURGH PA 15220
Ming Xian director MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202
Carl E Sassano director C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Joseph P Kelleman officer: (Interim) CFO 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Timothy G Robinson officer: Chief Financial Officer C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117